Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
4 Visninger
• 08/09/23
0
0
Indlejre
administrator
Abonnenter
Dr. Prince, Professor, The University of Melbourne and Monash University, talks about the outcomes of the ALCANZA study in CD30-expressing CTCL
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer